Details of the Drug

General Information of Drug (ID: DMXNPVE)

Drug Name

MRx-4DP0004

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Live biotherapeutic

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03851250) A First in Human, Double-blind, Placebo-controlled, Multicentre Phase I/II Study to Evaluate the Safety, Tolerability and Immune Modulatory Effects of MRx-4DP0004 in Participants Taking Long-term Control Medication for Their Asthma. U.S.National Institutes of Health.